Literature DB >> 2916940

Interactions of human colorectal carcinoma cells with basement membranes. Analysis and correlation with differentiation.

G W Daneker1, A J Piazza, G D Steele, A M Mercurio.   

Abstract

The abilities of colorectal carcinoma cell lines to adhere and invade through a basement membrane were examined. The four poorly differentiated cell lines studied were three to four times more adherent and spread to a greater extent following adherence to a basement membrane matrix than the three moderately well-differentiated (MWD) lines. One exception was the MWD cell line DLD-2, whose histologic features resembled a signet ring carcinoma. The ability of these cells to invade through a basement membrane model was measured. This assay showed that the poorly differentiated cell lines as well as DLD-2 were three times more invasive than the remaining MWD cell lines. These data indicate that tumor cell adherence can be correlated with invasion through basement membranes. In addition, the ability of colorectal carcinoma cells to interact with the basement membrane seems, in general, to be inversely related to the degree of cytodifferentiation.

Entities:  

Mesh:

Year:  1989        PMID: 2916940     DOI: 10.1001/archsurg.1989.01410020053009

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  3 in total

1.  Human colon carcinoma cells use multiple receptors to adhere to laminin: involvement of alpha 6 beta 4 and alpha 2 beta 1 integrins.

Authors:  M M Lotz; C A Korzelius; A M Mercurio
Journal:  Cell Regul       Date:  1990-02

2.  Distribution of type IV collagen immunoreactivity to assess questionable early stromal invasion.

Authors:  C J Stewart; A M McNicol
Journal:  J Clin Pathol       Date:  1992-01       Impact factor: 3.411

3.  Role of the E-cadherin/alpha-catenin complex in modulating cell-cell and cell-matrix adhesive properties of invasive colon carcinoma cells.

Authors:  E Breen; G Steele; A M Mercurio
Journal:  Ann Surg Oncol       Date:  1995-09       Impact factor: 5.344

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.